UB Paderborn / Katalog / Suche / in CDI

Outcomes After Liver Directed Radiation Therapy for Hepatocellular Carcinoma With Tumor Venous Thrombosis

International journal of radiation oncology, biology, physics, 2015-11, Vol.93 (3), p.E163-E164

2015

Link zum Volltext

Verfügbarkeit prüfen

The Prognostic Significance of T-Stage and N-Stage in Patients With Squamous Cell Carcinoma of the Oropharynx (OPSCC) in the HPV Era

International journal of radiation oncology, biology, physics, 2014-09, Vol.90 (1), p.S513-S513

2014

Link zum Volltext

Verfügbarkeit prüfen

Intraoperative Radiation Therapy in the Era of Intensive Neoadjuvant Chemotherapy and Chemoradiation Therapy for Pancreatic Adenocarcinoma

International journal of radiation oncology, biology, physics, 2016-10, Vol.96 (2), p.E209-E210

2016

Link zum Volltext

Verfügbarkeit prüfen

Clinical Predictors and Outcomes of Superior Mesenteric Vein or Portal Vein Thrombosis in the Setting of Neoadjuvant Therapy for Borderline Resectable or Locally Advanced Pancreatic Adenocarcinoma

International journal of radiation oncology, biology, physics, 2015-11, Vol.93 (3), p.E141-E141

2015

Link zum Volltext

Verfügbarkeit prüfen

Hippocampal Avoidance Whole Brain Radiotherapy with Reduced Whole Brain Dose in Patients with Non-Small Cell Lung Cancer Brain Metastases

International journal of radiation oncology, biology, physics, 2023-10, Vol.117 (2), p.e115-e116

2023

Link zum Volltext

Verfügbarkeit prüfen

Effect of Contralateral Esophagus Sparing in Hypofractionated Radiotherapy for Ultra-Central NSCLC

International journal of radiation oncology, biology, physics, 2023-10, Vol.117 (2), p.e82-e82

2023

Link zum Volltext

Verfügbarkeit prüfen

Risk of Esophagitis in Patients with Limited Stage SCLC Treated with QD or BID Chemoradiotherapy Regimens with Contralateral Esophagus Sparing

International journal of radiation oncology, biology, physics, 2023-10, Vol.117 (2), p.e29-e29

2023

Link zum Volltext

Verfügbarkeit prüfen

Management and Clinical Outcomes of Second Primary Lung Cancer in Women after Radiation Therapy for Breast Cancer

International journal of radiation oncology, biology, physics, 2020-11, Vol.108 (3), p.e72-e72

2020

Link zum Volltext

Verfügbarkeit prüfen

Esophagitis Outcomes With or Without Contralateral Esophagus Sparing in Locally Advanced Lung Cancer

International journal of radiation oncology, biology, physics, 2021-11, Vol.111 (3), p.e431-e431

2021

Link zum Volltext

Verfügbarkeit prüfen

Automated Clinical Target Volume Delineation for Non-Small Cell Lung Cancer Patients Using Deep 3D Networks

International journal of radiation oncology, biology, physics, 2020-11, Vol.108 (3), p.e347-e347

2020

Link zum Volltext

Verfügbarkeit prüfen

Expanding Role of Stereotactic Body Radiation Therapy (SBRT) for Lung Nodules in a Prospective Screening Cohort following Multidisciplinary Evaluation

International journal of radiation oncology, biology, physics, 2020-11, Vol.108 (3), p.S71-S72

2020

Link zum Volltext

Verfügbarkeit prüfen

Incidence of Pneumonitis in Metastatic Lung Cancer Patients Receiving Immune Checkpoint Inhibitors With or Without Thoracic Radiation Therapy

International journal of radiation oncology, biology, physics, 2017-10, Vol.99 (2), p.S150-S150

2017

Link zum Volltext

Verfügbarkeit prüfen

Decision Making in Octogenarians with Presumed Early-Stage Non-Small Cell Lung Cancer Treated with Empiric SBRT

International journal of radiation oncology, biology, physics, 2019-09, Vol.105 (1), p.E559-E559

2019

Link zum Volltext

Verfügbarkeit prüfen

Truncation of the PTV for Minimization of Risk of Chest Wall Toxicity in Patients Receiving SBRT for Stage I NSCLC

International journal of radiation oncology, biology, physics, 2019-09, Vol.105 (1), p.E505-E505

2019

Link zum Volltext

Verfügbarkeit prüfen

Association between Tumor Laterality and Cardiac Mortality in Patients with Non-Small Cell Lung Cancer Treated with Radiation

International journal of radiation oncology, biology, physics, 2018-11, Vol.102 (3), p.e697-e698

2018

Link zum Volltext

Verfügbarkeit prüfen

Integration of EGFR Inhibition With Radiation-Based Multimodality Treatment in Stage III EGFR Mutant NSCLC

International journal of radiation oncology, biology, physics, 2021-11, Vol.111 (3), p.e457-e457

2021

Link zum Volltext

Verfügbarkeit prüfen

Low Cardiopulmonary Toxicity With Use of IMRT When Delivering Postoperative Radiation Therapy (PORT) in Patients With NSCLC

International journal of radiation oncology, biology, physics, 2021-11, Vol.111 (3), p.e442-e443

2021

Link zum Volltext

Verfügbarkeit prüfen

High Baseline TNF-α Levels may Associate with Poor Outcomes after Total Neoadjuvant Therapy for Gastroesophageal Cancer: Initial Biomarker Analysis from a Prospective Study

International journal of radiation oncology, biology, physics, 2022-11, Vol.114 (3), p.e171

2022

Link zum Volltext

Verfügbarkeit prüfen

Phase I Trial of an IMRT-based Contralateral Esophagus Sparing Technique (CEST) in Locally Advanced NSCLC and SCLC Treated to 70 Gy

International journal of radiation oncology, biology, physics, 2020-11, Vol.108 (3), p.S104-S105

2020

Link zum Volltext

Verfügbarkeit prüfen

Quantitative Evaluation of Normal Lung Density Changes in Non-Small Cell Lung Cancer Patients Treated With Radiotherapy and PD-1 Immune Checkpoint Inhibitors

International journal of radiation oncology, biology, physics, 2021-11, Vol.111 (3), p.e131-e131

2021

Link zum Volltext

Verfügbarkeit prüfen

Clinical Correlates of Portal Venous or Superior Mesenteric Vein Thrombosis Following Neoadjuvant Therapy with Dose Escalated Radiation for Borderline Resectable or Locally Advanced Pancreatic Adenocarcinoma

International journal of radiation oncology, biology, physics, 2021-11, Vol.111 (3), p.e77-e78

2021

Link zum Volltext

Verfügbarkeit prüfen

Total Neoadjuvant Therapy versus Neoadjuvant Chemoradiotherapy in the Management of Gastric Cancer

International journal of radiation oncology, biology, physics, 2020-11, Vol.108 (3), p.e602-e603

2020

Link zum Volltext

Verfügbarkeit prüfen

Neoadjuvant versus Postoperative Chemoradiotherapy in Gastric Cancer

International journal of radiation oncology, biology, physics, 2020-11, Vol.108 (3), p.e632-e632

2020

Link zum Volltext

Verfügbarkeit prüfen

A Pilot Study of Neoadjuvant FOLFIRINOX followed by Chemoradiation for Gastric and Gastroesophageal Cancer: Preliminary Results and Prognostic Implications of ctDNA

International journal of radiation oncology, biology, physics, 2019-09, Vol.105 (1), p.S85-S86

2019

Link zum Volltext

Verfügbarkeit prüfen

Intraoperative radiation therapy (IORT) for borderline resectable and locally advance pancreatic cancer (BR/LA PDAC) in the era of modern neoadjuvant treatment: short- and long-term outcomes

HPB (Oxford, England), 2019-03, Vol.21, p.S82-S82

2019

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Outcomes After Liver Directed Radiation Therapy for Hepatocellular Carcinoma With Tumor Venous Thrombosis

The Prognostic Significance of T-Stage and N-Stage in Patients With Squamous Cell Carcinoma of the Oropharynx (OPSCC) in the HPV Era

Intraoperative Radiation Therapy in the Era of Intensive Neoadjuvant Chemotherapy and Chemoradiation Therapy for Pancreatic Adenocarcinoma

Clinical Predictors and Outcomes of Superior Mesenteric Vein or Portal Vein Thrombosis in the Setting of Neoadjuvant Therapy for Borderline Resectable or Locally Advanced Pancreatic Adenocarcinoma

Hippocampal Avoidance Whole Brain Radiotherapy with Reduced Whole Brain Dose in Patients with Non-Small Cell Lung Cancer Brain Metastases

Effect of Contralateral Esophagus Sparing in Hypofractionated Radiotherapy for Ultra-Central NSCLC

Risk of Esophagitis in Patients with Limited Stage SCLC Treated with QD or BID Chemoradiotherapy Regimens with Contralateral Esophagus Sparing

Management and Clinical Outcomes of Second Primary Lung Cancer in Women after Radiation Therapy for Breast Cancer

Esophagitis Outcomes With or Without Contralateral Esophagus Sparing in Locally Advanced Lung Cancer

Automated Clinical Target Volume Delineation for Non-Small Cell Lung Cancer Patients Using Deep 3D Networks

Expanding Role of Stereotactic Body Radiation Therapy (SBRT) for Lung Nodules in a Prospective Screening Cohort following Multidisciplinary Evaluation

Incidence of Pneumonitis in Metastatic Lung Cancer Patients Receiving Immune Checkpoint Inhibitors With or Without Thoracic Radiation Therapy

Decision Making in Octogenarians with Presumed Early-Stage Non-Small Cell Lung Cancer Treated with Empiric SBRT

Truncation of the PTV for Minimization of Risk of Chest Wall Toxicity in Patients Receiving SBRT for Stage I NSCLC

Association between Tumor Laterality and Cardiac Mortality in Patients with Non-Small Cell Lung Cancer Treated with Radiation

Integration of EGFR Inhibition With Radiation-Based Multimodality Treatment in Stage III EGFR Mutant NSCLC

Low Cardiopulmonary Toxicity With Use of IMRT When Delivering Postoperative Radiation Therapy (PORT) in Patients With NSCLC

High Baseline TNF-α Levels may Associate with Poor Outcomes after Total Neoadjuvant Therapy for Gastroesophageal Cancer: Initial Biomarker Analysis from a Prospective Study

Phase I Trial of an IMRT-based Contralateral Esophagus Sparing Technique (CEST) in Locally Advanced NSCLC and SCLC Treated to 70 Gy

Quantitative Evaluation of Normal Lung Density Changes in Non-Small Cell Lung Cancer Patients Treated With Radiotherapy and PD-1 Immune Checkpoint Inhibitors

Clinical Correlates of Portal Venous or Superior Mesenteric Vein Thrombosis Following Neoadjuvant Therapy with Dose Escalated Radiation for Borderline Resectable or Locally Advanced Pancreatic Adenocarcinoma

Total Neoadjuvant Therapy versus Neoadjuvant Chemoradiotherapy in the Management of Gastric Cancer

Neoadjuvant versus Postoperative Chemoradiotherapy in Gastric Cancer

A Pilot Study of Neoadjuvant FOLFIRINOX followed by Chemoradiation for Gastric and Gastroesophageal Cancer: Preliminary Results and Prognostic Implications of ctDNA

Intraoperative radiation therapy (IORT) for borderline resectable and locally advance pancreatic cancer (BR/LA PDAC) in the era of modern neoadjuvant treatment: short- and long-term outcomes

Suchergebnisse filtern